Alethea Capital Management’s CVS Health CVS Stock Holding History

Alethea Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,055	Closed	-$239K	–	38
2024 Q2	$239K	Buy	+4,055	New	+$254K	0.18%	28
2024 Q1	–	Sell	-3,300	Closed	-$261K	–	38
2023 Q4	$261K	Hold	3,300	–	–	0.3%	30
2023 Q3	$230K	Sell	3,300 -7,604	-70%	-$539K	0.28%	49
2023 Q2	$754K	Buy	10,904 +684	+7%	+$48.7K	0.81%	10
2023 Q1	$759K	Buy	10,220 +6,920	+210%	+$580K	0.8%	8
2022 Q4	$308K	Hold	3,300	–	–	0.29%	26
2022 Q3	$315K	Hold	3,300	–	–	0.4%	33
2022 Q2	$306K	Hold	3,300	–	–	0.38%	48
2022 Q1	$334K	Hold	3,300	–	–	0.3%	51
2021 Q4	$340K	Hold	3,300	–	–	0.29%	52
2021 Q3	$280K	Hold	3,300	–	–	0.25%	64
2021 Q2	$275K	Hold	3,300	–	–	0.17%	68
2021 Q1	$248K	Sell	3,300 -6,502	-66%	-$474K	0.15%	68
2020 Q4	$669K	Buy	+9,802	New	+$638K	0.34%	31
2019 Q2	–	Sell	-10,646	Closed	-$574K	–	88
2019 Q1	$574K	Buy	+10,646	New	+$657K	0.41%	33
2018 Q3	–	Sell	-8,335	Closed	-$536K	–	79
2018 Q2	$536K	Buy	+8,335	New	+$549K	0.92%	27
2017 Q3	–	Sell	-31,859	Closed	-$2.56M	–	85
2017 Q2	$2.56M	Buy	+31,859	New	+$2.52M	2.91%	5

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Alethea Capital Management's CVS Position: Q3 2024 in Review

Alethea Capital Management sold out of CVS Health (CVS) in Q3 2024, closing a stake of 4,055 shares — an estimated $239K sold.

Alethea Capital Management first reported a position in CVS in Q2 2017 and held it in 17 quarters. The position peaked at $2.56M in Q2 2017. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Alethea Capital Management reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Alethea Capital Management sold 4,055 CVS Health shares in Q3 2024, an estimated $239K.
Alethea Capital Management first reported a position in CVS Health in Q2 2017 and held it in 17 quarters.
Alethea Capital Management's CVS Health position peaked at $2.56M in Q2 2017.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Alethea Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.